Today, $INSM (+0,45%) is having an explosive session (currently up +13% and climbing), which has pushed my long-term positions to a total profit of +161%.
For many, this is just "today's news." For me, it's the *validationof an investment thesis I built over 15 months ago.
This isn't luck. This is analysis, conviction, and patience. Let's break down the facts.
📈 Today’s Catalyst: The Q3 2025 Earnings Analysis
The market is reacting with euphoria today for a very specific reason: the Q3 2025 earnings report.
A hasty investor might see the EPS (Earnings Per Share) of -$1.75, which missedanalyst estimates, and get confused. But the smart money is forward-looking.
The *realdrivers behind today's surge are two fundamental data points that overpower everything else:
1. 💰 REVENUE BEAT: The company reported $142.3 million in revenue, smashing expectations. This demonstrates strong commercial execution and growing demand.
2. 🎯 RAISED GUIDANCE: This is the real game-changer. Insmed has raised its full-year 2025 sales forecast for its key drug, ARIKAYCE.
The takeaway: The market isn't buying the past (the EPS miss); it's buying the future (the confirmed, expected growth).
🧠 My Strategy: The 15+ Month Patience Game
This +161% isn't the result of a day trade. It's the result of a fundamental Buy & Hold strategy that I initiated back in July 2024.
Entry 1: 07/09/2024 @ $69.87
Entry 2: 07/16/2024 @ $77.52
At that time, the stock was far from the spotlight, trading near its lows.
My investment thesis was clear:
1. Solid Pipeline: I analyzed the potential of Insmed's pipeline, especially in the orphan lung disease space—a market with a massive unmet medical need.
2. Undervaluation: The market was pricing in the risk but massively under-appreciating the long-term revenue potential of their approved and developing drugs.
3. Execution: I made a bet on management's ability to execute their commercial strategy and bring their products to market effectively.
I have held these positions for over 15 months, sitting through volatility, market noise, and interim reports, because my conviction in the company's long-term fundamentals never wavered.
Today's report is simply the market catching up to that thesis. 💎🙌
Successful investing isn't about timing the day; it's about being right on the long-term value. Congratulations to all fellow $INSM bulls who held strong! 🤝
Follow the Analysis:
For daily real-time market insights, *deep dives*, and trading discussions, follow me on X: https://x.com/ThomasVioli
To copy my portfolio, strategies, and complete trade insights, you can follow me on eToro: https://www.eToro.com/people/farlys
⚠️ Disclaimer: Past performance is not indicative of future results. Investing involves risks, including the loss of capital.
This is a share of my personal analysis and strategy. It does not constitute financial advice.